At first glance this was huge news with chemical implications: $300 billion would be an extraordinary investment for a refinery, many times more than was put into China’s giant Zhejiang Petroleum and ...
Cambridge biotech company Mestag Therapeutics has closed a $40 million financing round and added two senior executives to its ...
According to new analysis by Future Market Insights, the global personal care and cosmetics microalgae market is emerging as ...
Rapid advancement of emerging technologies, including nuclear technology, artificial intelligence, biotechnology, continue to expand the scope of dual-use risks. How are the scientific innovations ...
Monday, March 16th at 1:30 PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA ...
DorsaVi (ASX: DVL) has announced two significant commercial milestones, the Dr Patel collaboration and the SEROMA European study, totalling over A$200,000 in contracted revenue. T ...
London biotech startup Ternary Therapeutics has raised £3.6m to scale its AI-powered platform designed to engineer molecular ...
Wall Street's attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...
A collage of images including people in a lab, Chinese currency, and a person wearing full personal protective gear and ...
Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn ...
Company leaders to engage the global research community on circular RNA, AI-driven therapeutics, and next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results